Aspirus Riverview Hospital & Clinics, INC.
Aspirus Riverview Hospital & Clinics, INC. was paid $385K by Medicaid between Jan 2018 and Dec 2024, across 40 billing codes. Its largest line is 80061, Lipid panel — 17% of everything it billed.
WISCONSIN RAPIDS, WI 54494
Next to other Clinical Medical Laboratory providers in Wisconsin
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Paid by month
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 1,437 | $31K | |
| 2019 | 3,458 | $32K | |
| 2020 | 4,975 | $96K | |
| 2021 | 8,107 | $72K | |
| 2022 | 5,739 | $75K | |
| 2023 | 4,716 | $43K | |
| 2024incomplete | 3,994 | $36K |
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 80061 | Lipid panel | 17% | 6,368 | 5,871 | $67K |
| 84443 | Thyroid stimulating hormone (TSH) | 17% | 5,101 | 4,637 | $64K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 15% | 745 | 652 | $59K |
| 80053 | Comprehensive metabolic panel | 7.2% | 3,538 | 3,022 | $28K |
| 87624 | Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types | 6.5% | 779 | 709 | $25K |
| G0123 | Screening cytopathology, cervical or vaginal (any reporting system), collected in preservative fluid, automated thin layer preparation, screening by cytotechnologist under physician supervision | 6.1% | 1,182 | 1,065 | $24K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 4.8% | 3,458 | 2,877 | $18K |
| 87636 | Infectious agent detection by nucleic acid; SARS-CoV-2 and influenza virus types A and B | 4.3% | 125 | 122 | $17K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 3.2% | 265 | 253 | $12K |
| 84439 | 2.6% | 1,437 | 1,312 | $10K | |
| 82728 | 1.9% | 744 | 688 | $7K | |
| 80050 | General health panel | 1.7% | 441 | 178 | $7K |
28 more codes
| 80306 | 1.7% | 458 | $6K | |
| 85027 | 1.6% | 1,169 | $6K | |
| 83036 | Hemoglobin; glycosylated (A1C) | 1.5% | 778 | $6K |
| 80048 | Basic metabolic panel (calcium, ionized) | 1.4% | 805 | $5K |
| 86140 | 1.1% | 1,021 | $4K | |
| 83735 | <1% | 560 | $3K | |
| 80081 | <1% | 155 | $2K | |
| 81001 | <1% | 967 | $2K | |
| 87637 | Infectious agent detection by nucleic acid; SARS-CoV-2, influenza, and RSV | <1% | 18 | $2K |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 43 | $2K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 43 | $2K |
| 86803 | <1% | 86 | $1K | |
| 85007 | <1% | 301 | $932.53 | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | <1% | 74 | $694.50 |
| 87653 | <1% | 13 | $559.83 | |
| 84153 | <1% | 31 | $475.01 | |
| 86850 | <1% | 158 | $459.29 | |
| 87210 | <1% | 98 | $437.33 | |
| 84702 | <1% | 36 | $336.97 | |
| 85610 | <1% | 78 | $246.52 | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 34 | $225.33 |
| 87400 | <1% | 12 | $194.58 | |
| 86900 | <1% | 73 | $148.75 | |
| 86901 | <1% | 73 | $142.77 | |
| 85652 | <1% | 51 | $104.49 | |
| 87070 | <1% | 13 | $95.25 | |
| 82950 | <1% | 12 | $42.16 | |
| 36415 | Collection of venous blood by venipuncture | <1% | 1,083 | $39.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
Who's on the registration
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.